sabato, 5 dicembre 2020
Medinews
26 Gennaio 2018

Supplements to Help Prevent Neuropathy During Chemotherapy? A Cautionary Tale

Chemotherapy-induced peripheral neuropathy (CIPN) remains a common and challenging treatment-related toxicity of many anticancer therapies. Sensory neuropathy involving the hands and/or feet has been observed in more than 70% of women with localized breast cancer receiving a taxane. Some of these neuropathies have a profound and disabling impact on an individual’s quality of life, with the majority of those affected experiencing persistent symptoms at 12 months … (leggi tutto)

TORNA INDIETRO